Cantor Fitzgerald analyst Scott Keeney questioned Joe Corso regarding business margins and tariff impacts.
1 report, 0 independent
Updated Jun 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald analyst Scott Keeney questioned Joe Corso regarding business margins and tariff impacts.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Scott Keeney
American entrepreneur
Nothing else this week.
-
Cantor Fitzgerald
American financial services company
Related events
- Cantor Fitzgerald initiated coverage citing a durable business model, and Morgan Stanley provided analyst commentary on Samsara.
- Cantor Fitzgerald, Morgan Stanley, and Royal Bank of Canada issued price target updates for Elevance Health, Inc. on September 12, 2026.
- Analyst coverage impacts market perception, involving Rexford Industrial Realty and Cantor Fitzgerald.
- Cantor Fitzgerald raised its price target and rating for Supernus Pharmaceuticals, Inc. on September 2, 2026, and the company filed a disclosure with the SEC.
- Cantor Fitzgerald set a $46.00 price objective involving the company and Alaska Airlines.
Coverage
Newest first; wire copies grouped- Unknown outlet